CURRENT REPORT

Company

Emmaus Life Sciences, Inc.

Filed

February 26, 2024

Period of Report

February 21, 2024

Accession Number

0001213900-24-016715

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →